Innovation

Baylor, MD Anderson cancer therapies advance toward commercialization


By Christine Hall | September 5, 2018

Having an idea begin in the laboratory and become a viable treatment or therapy for patients is a goal for researchers across the Texas Medical Center.

Recently, two TMC member institutions saw their cancer therapies gain the distinction of advancing to commercialization.

Ann Leen, Ph.D., and Juan Vera, M.D., along with their colleagues at the Center for Cell and Gene Therapy at Baylor College of Medicine as well as Texas Children’s Hospital and Houston Methodist, developed a therapy for cancer patients that harnesses the patient’s own immune system to fight cancer. The treatment uses a ‘natural’ T cell response that does not require genetic engineering.

In 2015, the group members formed Marker Therapeutics Inc. to facilitate broader patient access to the therapy. Now, Marker is merging with TapImmune Inc., a Florida-based publicly traded company that develops novel immunotherapies for cancer.

The proposed alliance will enable the researchers to perform “advanced-stage clinical testing” to “realize the goal of making immunotherapy a mainstream therapy for patients,” Leen said in a statement.

The partnership also includes a strategic alliance that involves sponsored research, manufacturing support and advancing early-stage clinical trials at Baylor.

Since 2010, more than 25 companies were created within Baylor College of Medicine to advance research from the lab to commercialization, according to Michael Dilling, director of the Baylor Licensing Group, which helps develop commercial relationships that lead to agreements supporting new products and services from Baylor research.

“Entrepreneurial activity has been increasing at Baylor,” he said. “In Marker’s case, that area of development in cell-based therapy is a hot area, and there is commercial interest.”

Meanwhile, The University of Texas MD Anderson Cancer Center has its own history of establishing companies to advance therapies under development within its institution.

“Houston is an untapped gem in the life sciences universe, and this fits with the way Accelerator approaches things,” said David Schubert, chief operating partner at Accelerator Life Science Partners. “There is a lot of great stuff here, which tends to be really early, but driven by powerhouses like MD Anderson, and I am a big believer of what’s going on here.”

This month, MD Anderson and New York-based investment and management firm Accelerator Life Science Partners launched Magnolia Neurosciences Corp.—a company developing a new class of medicines aimed at helping patients suffering from neurodegenerative conditions, such as Alzheimer’s disease and chemotherapy-induced neuropathy in cancer patients.

Magnolia will develop novel therapeutics based on discoveries made by researchers in MD Anderson’s Therapeutics Discovery division, which includes more than 100 clinicians, researchers and drug discovery scientists working to develop innovative treatment options including small molecules, biologics and cell-based therapies.

“This is a really powerful group and we are excited,” said Ferran Prat, Ph.D., vice president of strategic industry ventures at MD Anderson.

Magnolia received $31 million in Series A funding—its first round of venture capital funding.

“Before, it would have been difficult to get investors, but we have established a good track record and have those connections that are on par with the Stanfords and Harvards of the world,” Prat added.

Magnolia also provides David Schubert, chief operating partner at Accelerator, a chance to further his work in Houston. He served as executive director of the Houston Area Translational Research Consortium at Rice University until 2014 and collaborated with Prat since then to understand how the innovation ecosystem works.

“Houston is an untapped gem in the life sciences universe, and this fits with the way Accelerator approaches things,” he said. “There is a lot of great stuff here, which tends to be really early, but driven by powerhouses like MD Anderson, and I am a big believer of what’s going on here.”




Social Posts

profile_image

Memorial Hermann

@memorialhermann

This spiced beet salad is a sure crowd-pleaser to bring to your #holiday gathering. Get the recipe here: https://t.co/V65Qt0OcnM. #healthyfood https://t.co/VsuU5nrMn0

30 mins ago
profile_image

Rice University

@RiceUniversity

Even though this lightweight material is full of holes, it's nearly as hard as diamond and stops bullets better than solid materials: https://t.co/N1QBG6C6yz https://t.co/CZTLL3qyDf

43 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

Today’s #VeteranOfTheDay is Army Veteran Boris A. Stern, who fought at the Battle of the Bulge and Battle of the Rhineland during World War II: https://t.co/4GVemb8y4p

58 mins ago
profile_image

Texas Children's

@TexasChildrens

Dr. Lisa Gaw, pediatrician and director at Texas Children’s Urgent Care Westgate, weighs in via @austin360: https://t.co/krYY7O3tuR

1 hour ago
profile_image

Texas Children's

@TexasChildrens

RT @austin360: The holidays are upon us, and so is the increased eating and the risk of choking. Make sure you know what to do ⤵ https://t.…

1 hour ago
profile_image

Texas Children's

@TexasChildrens

RT @LinaHidalgoTX: Today I toured the Texas Children’s Hospital @TexasChildrens to learn about the incredible work that they do. The amazin…

1 hour ago
profile_image

BCMHouston

@bcmhouston

How is your social media habits effecting your kids? Dr. Laurel Williams explains. https://t.co/04xUcmpG93 #socialmedia #mentalhealth

1 hour ago
profile_image

BCMHouston

@bcmhouston

RT @ARosen380: True honor and privilege to present today on our work in Colorectal Cancer Outreach and education at @BCMCancerCenter at @NC…

2 hours ago
profile_image

BCMHouston

@bcmhouston

RT @BCMCancerCenter: Did you know today is World Pancreatic Cancer Day? Learn more about our clinical trials for this disease. https://t.co…

2 hours ago
profile_image

TexasHeartInstitute

@Texas_Heart

Do economic factors contribute to heart disease death rates? A preliminary study says heart disease deaths increased in counties hit hard by the 2008-09 recession. https://t.co/TkD0lBZn0z via @UPI

2 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

“Don’t delay seeing a doctor if you think something’s wrong. You know your body better than anyone else,” says Herman Connor, a #kidneycancer survivor: https://t.co/O3s3i59PMl #endcancer https://t.co/pmH1LDTmGT

2 hours ago
profile_image

University of Houston

@UHouston

We are excited to announce a virtual tour that will allow you to explore campus like never before. Check it out now on our homepage or the UH Go Mobile App. #GoCoogs! https://t.co/MfuoO4vMB8

2 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

@wfpinky @cher @benatargiraldo Safe travels, Marissa.

2 hours ago
profile_image

Rice University

@RiceUniversity

RT @RiceUNews: We can’t yet build with unlimited piles of diamond, no. But @RiceUniversity researchers have figured out the next best thing…

3 hours ago
profile_image

Harris Health System

@harrishealth

More than 34 million Americans smoke, and smoking remains the largest preventable cause of death and illness in the world. Smoking causes an estimated 480,000 deaths every year. Make the decision to quit smoking today! #GreatAmericanSmokeouthttps://t.co/n4c7C3vqTp https://t.co/ebXcuhTouS

3 hours ago